Mitozantrone (HCl) Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Oseltamivir Manufacturers of Oseltamivir Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Oseltamivir's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 10 to 12 mg/ sq.meter11 (11)As recommended.IVDose may be Repeat at 21 day interval Paedriatic Dosage (20kg) 12 mg/sq metre22 (22)24 hourlyIntravenousFor 3 days Neonatal Dosage (3kg) 0.4 mg/kg0.4 (0.4)24 hourlyIntravenousFor 3---5 days High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Oseltamivir Back to top Manufacturers of Mitozantrone (HCl) in Pakistan Atco Bio Pharma Neo Back to top Previous Drug Generic - Next Drug Generic
Mitozantrone (HCl) Overview Categories 8 Antineoplastics, immunomodulators and drugs used in palliative care8.2 Cytotoxic (anti-neoplastic) drugs Page headings Overview Primary Characterstics Indications Pharmacokinetics Contraindications Drug Interactions Side Effects Dosage High Risk Groups Warning / Precautions Storage Conditions Interference in Pathology Brands of Oseltamivir Manufacturers of Oseltamivir Primary Characterstics Indications Back to top Pharmacokinetics Back to top Contraindications Back to top Drug Interactions Back to top Side Effects Back to top Dosage Oseltamivir's dosage details are as follows: Dose Single Dose Frequency Route Instructions Adult Dosage 10 to 12 mg/ sq.meter11 (11)As recommended.IVDose may be Repeat at 21 day interval Paedriatic Dosage (20kg) 12 mg/sq metre22 (22)24 hourlyIntravenousFor 3 days Neonatal Dosage (3kg) 0.4 mg/kg0.4 (0.4)24 hourlyIntravenousFor 3---5 days High Risk Groups Back to top Warning / Precautions Back to top Storage Conditions Back to top Interference in Pathology Back to top Brands / Trade Names of Oseltamivir Back to top Manufacturers of Mitozantrone (HCl) in Pakistan Atco Bio Pharma Neo Back to top Previous Drug Generic - Next Drug Generic